Acute Lung Injury clinical trials at UCSD

• The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

  open to eligible people ages 18-75

  This is a multicenter, single-treatment study. Subjects will consist of adults with COVID-19 associated acute lung injury who are being cared for in a critical care environment.

  La Jolla, California and other locations

Last updated: August 18, 2021